Ironwood Pharmaceuticals | IRWD - EPS Earnings Per Share


Ironwood Pharmaceuticals reported $0.24 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.36 0.24 Oct/29
FY2026Q2 Jun/2026 0.38 0.14 Aug/06
FY2025Q1 Mar/2026 0.24 0.19 -0.12 May/07




Eps Change Date
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
Agios Pharmaceuticals USD -1.69 0.17 Mar/2026
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Almirall EUR 0.07 0.03 Dec/2025
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
Amarin USD 0.14 0.06 Dec/2025
Ardelyx USD -0.15 0.15 Mar/2026
Astellas Pharma JPY 24.29 31.75 Mar/2026
AstraZeneca USD 2.58 0.46 Mar/2026
Charles River Laboratories USD 2.06 0.33 Mar/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Halozyme Therapeutics USD 1.6 1.84 Mar/2026
Incyte USD 1.81 0.01 Mar/2026
Ironwood Pharmaceuticals USD 0.24 0.25 Mar/2026
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
MacroGenics USD -0.58 0.36 Mar/2026
Moderna USD -3.4 1.29 Mar/2026
Myriad Genetics USD -0.09 0.13 Mar/2026
Pacira USD 0.6 0.54 Mar/2026
PTC Therapeutics USD -0.03 1.64 Mar/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Takeda JPY -15.56 81.3 Mar/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024